- Home
- EMO vs MDXG Comparison
EMO vs MDXG Comparison
Compare EMO & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EMO | MDXG |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | EMO | MDXG |
|---|---|---|
| Price | $50.88 | $3.90 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 45.8K | ★ 869.8K |
| Earning Date | 01-01-0001 | 04-29-2026 |
| Dividend Yield | ★ 6.70% | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | N/A | ★ 0.32 |
| Revenue | N/A | ★ $418,630,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $13.02 |
| P/E Ratio | ★ N/A | $12.25 |
| Revenue Growth | N/A | ★ 19.99 |
| 52 Week Low | $41.54 | $3.77 |
| 52 Week High | $54.90 | $7.99 |
Technical Indicators
Market Signals| Indicator | EMO | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 41.79 | 28.26 |
| Support Level | $51.00 | N/A |
| Resistance Level | $54.44 | $7.39 |
| Average True Range (ATR) | 1.26 | 0.15 |
| MACD | -0.34 | 0.00 |
| Stochastic Oscillator | 16.43 | 20.00 |
Price Performance
Historical ComparisonAbout EMO ClearBridge Energy Midstream Opportunity Fund Inc.
ClearBridge Energy Midstream Opportunity Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide long-term investors with a high level of total return with an emphasis on cash distributions. The Fund considers investments in midstream entities as those entities that provide midstream services including the gathering, transporting, processing, fractionation, storing, refining, and distribution of oil, natural gas liquids and natural gas.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.